eukaryotic translation initiation factor 3 subunit H
| GO Term | Evidence Code | PMID |
|---|---|---|
| formation of cytoplasmic translation initiation complex |
|
|
| formation of cytoplasmic translation initiation complex |
|
|
| cytoplasmic translational initiation |
|
|
| translational initiation |
|
|
| translational initiation |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| cytoplasm |
|
|
| cytosol |
|
|
| eukaryotic translation initiation factor 3 complex |
|
|
| eukaryotic translation initiation factor 3 complex |
|
|
| eukaryotic translation initiation factor 3 complex |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| RNA binding |
|
|
| translation initiation factor activity |
|
|
| translation initiation factor activity |
|
|
| translation initiation factor activity |
|
|
| translation initiation factor activity |
|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:10286 | prostate carcinoma | |
| DOID:10283 | prostate cancer | |
| DOID:1612 | breast cancer |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026